Public stigma: the community's tolerance of Alzheimer disease

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Sergio Luís Blay, Erica Toledo Pisa Peluso

Abstract

To investigate public stigma relating to Alzheimer disease (AD) and variables correlated with this outcome. Cross-sectional study. City of São Paulo, Brazil. A representative sample of 500 individuals aged 18-65 years, living within the community. Subjects were interviewed to assess three dimensions of stigma (stereotypes, prejudice, and discrimination). Stigma was considered present in this study when all three domains were simultaneously fulfilled. The 41.6% of the participants expressed stereotypes; 43.4% prejudice; and 35.5% discrimination. Among the whole sample, 14.8% endorsed the stigma definition criterion adopted for this study. Those with fewer years of education were 2.32 times as likely to stigmatize persons carrying AD. Stigma was unaffected by other sociodemographic variables, experience of mental illness, emotional reactions, or general information about AD. Dimensions of stigma were highly prevalent in relation to AD. Interventions are needed to reduce the negative effects of stigma.

References

Jul 1, 1989·Acta Psychiatrica Scandinavica·D Bhugra
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·I F BrockingtonC Murphy
Feb 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·G WolffJ Leff
Sep 20, 2000·Alzheimer Disease and Associated Disorders·J S Roberts, C M Connell
Mar 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·R Haghighat
Sep 6, 2003·Acta Psychiatrica Scandinavica·M C Angermeyer, H Matschinger
Oct 18, 2003·Social Psychiatry and Psychiatric Epidemiology·E Oryal TaskinIlkin Icelli
Oct 27, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·Christoph LauberWulf Rössler
Dec 8, 2004·Social Psychiatry and Psychiatric Epidemiology·Erica de Toledo Piza Peluso, Sérgio Luís Blay
Jun 14, 2005·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Jon VeloskiDavid B Nash
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Nicolas RüschPatrick W Corrigan
Feb 1, 2006·Acta Psychiatrica Scandinavica. Supplementum·D Bhugra
Feb 10, 2006·Acta Psychiatrica Scandinavica·M C Angermeyer, S Dietrich
Apr 28, 2007·Social Science & Medicine·Winnie W S MakShu Fai Cheung
Mar 5, 2008·Alzheimer Disease and Associated Disorders·Sergio Luís Blay, Erica de Toledo Piza Peluso
Apr 1, 2008·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Erica de Toledo Piza Peluso, Sérgio Luís Blay
May 27, 2008·Social Psychiatry and Psychiatric Epidemiology·Erica de Toledo Piza PelusoSérgio Luís Blay
Oct 10, 2008·Journal of Affective Disorders·Erica de Toledo Piza Peluso, Sérgio Luís Blay

❮ Previous
Next ❯

Citations

Nov 26, 2013·International Psychogeriatrics·Olaf von dem KnesebeckChristopher Kofahl
May 24, 2012·Dementia and Geriatric Cognitive Disorders Extra·Angélique Faure-DelagePhilippe Nubukpo
Dec 21, 2010·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Georg SchomerusMatthias C Angermeyer
Mar 6, 2012·Social Science & Medicine·Baldwin Van Gorp, Tom Vercruysse
Feb 7, 2015·BMC Geriatrics·Michael J AnnearAndrew Robinson
Mar 15, 2015·Aging & Mental Health·D GoveN Small
Apr 10, 2015·The American Journal of Bioethics : AJOB·Stanley KorenmanJohn M Ringman
Jun 21, 2016·Journal of Clinical Nursing·Robin DigbyAllison Williams
Nov 3, 2012·The International Journal of Social Psychiatry·Ivona Milačić-VidojevićNada Dragojević
May 12, 2017·Journal of Clinical Nursing·Robin DigbyAllison Williams
Jun 12, 2016·Dementia·Debby L GerritsenDianne Gove
Mar 15, 2019·Journal of the American Psychiatric Nurses Association·Ruth Palan LopezJennifer Duncan Davis
Mar 22, 2014·Geriatrics & Gerontology International·Yohko Maki, Haruyasu Yamaguchi
Apr 1, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Shana D StitesJason Karlawish
Oct 27, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Perla WernerShmuel Eidelman
Feb 13, 2020·Aging & Mental Health·Nicolas FarinaRachael Frost
Sep 12, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A N Bogolepova
Mar 23, 2017·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Nels OscarKaren Hooker
Apr 9, 2019·Aging & Mental Health·Fan Zhang, Sheung-Tak Cheng
Oct 28, 2019·International Psychogeriatrics·Sergio Luís Blay, Érica Toledo Piza Peluso
Nov 21, 2012·International Journal of Geriatric Psychiatry·Leslie Cartz PiverJean-Pierre Clément
Oct 23, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Agustin IbanezJennifer S Yokoyama
Nov 14, 2020·Journal of Alzheimer's Disease : JAD·Magdalena Rewerska-Juśko, Konrad Rejdak
Jul 27, 2021·Soins. Gérontologie·Claire SanlavilleLaurent Letrilliart
Jul 13, 2021·Journal of Alzheimer's Disease : JAD·Perla Werner, Sarang Kim
Jun 10, 2021·Current Alzheimer Research·Richard S HenryJose A Soto-Escageda
Nov 5, 2021·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Carrie McAineyJennifer Boger
Nov 14, 2021·Aging & Mental Health·Jean GajardoLaura N Gitlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.